🇺🇸 FDA
Pipeline program

BICX104

BioCorRx-21-01a

Phase 1 small_molecule completed

Quick answer

BICX104 for Opioid-use Disorder is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Opioid-use Disorder
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials